Pharma Layoffs Hit Nine Firms in 2026 Opener
January 26, 2026
At least nine companies including Takeda and Sonoma Biotherapeutics announced layoffs in January 2026 amid pipeline setbacks and cost pressures.
Takeda Neuroscience Layoffs Hit 243 Ahead of Trintellix Patent Loss
January 20, 2026
Takeda lays off 243 US workers, mainly neuroscience sales reps, as Trintellix faces patent expiry and generic competition.
Takeda Partners Halozyme on Vedolizumab ENHANZE SC
January 8, 2026
Takeda enters global collaboration and licence with Halozyme to develop subcutaneous vedolizumab using ENHANZE technology for IBD patients.